|
Jul 21
|
Urinary Incontinence Devices Company Evaluation Report 2025 | Coloplast, B. Braun, and Johnson & Johnson Lead the Market with Innovation, Global Expansion, and Diversified Healthcare Portfolios
|
|
Jul 20
|
10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever
|
|
Jul 19
|
S&P 500, Nasdaq 100 hit fresh highs as even retail scores wins over the week
|
|
Jul 19
|
Johnson & Johnson’s (JNJ) Dividend Track Record: Reliability in Uncertain Times
|
|
Jul 18
|
Earnings live: Second quarter earnings season off to strong start with Tesla, Google on deck
|
|
Jul 18
|
J&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?
|
|
Jul 18
|
FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
|
|
Jul 18
|
Johnson & Johnson price target raised to $167 from $164 at Guggenheim
|
|
Jul 18
|
Top Dividend Stocks To Consider In July 2025
|
|
Jul 18
|
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
|
|
Jul 18
|
3M sees smaller tariff hit on 2025 profit amid easing US-China trade tensions
|
|
Jul 18
|
Guggenheim Maintained a Hold Rating on Johnson & Johnson (JNJ)
|
|
Jul 18
|
Carlsmed seeks up to $103M IPO haul to fuel spine surgery growth
|
|
Jul 17
|
Watch These Johnson & Johnson Price Levels After Stock's Post-Earnings Pop
|
|
Jul 17
|
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook
|
|
Jul 17
|
Company News for Jul 17, 2025
|
|
Jul 17
|
Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down
|
|
Jul 17
|
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
|
|
Jul 17
|
3 Top Dividend Stocks to Maximize Your Retirement Income
|
|
Jul 17
|
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer
|